Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis.

Yoon HY, Park SY, Lee CH, Byun MK, Na JO, Lee JS, Lee WY, Yoo KH, Jung KS, Lee JH.

Int J Chron Obstruct Pulmon Dis. 2019 Jun 28;14:1389-1397. doi: 10.2147/COPD.S205517. eCollection 2019.


Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications.

Lee JH, Rhee CK, Kim K, Kim JA, Kim SH, Yoo KH, Kim WJ, Park YB, Park HY, Jung KS.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 12;12:1135-1144. doi: 10.2147/COPD.S130140. eCollection 2017.


[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].

Ning P, Guo YF, Sun TY, Zhang HS, Chai D, Li XM.

Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005. Chinese.


Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.

Baumeler L, Papakonstantinou E, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Kostikas K, Blasi F, Boersma W, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D.

Respirology. 2016 Jul;21(5):883-90. doi: 10.1111/resp.12758. Epub 2016 Mar 11.


Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.

Chai CS, Liam CK, Pang YK, Ng DL, Tan SB, Wong TS, Sia JE.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:565-573. doi: 10.2147/COPD.S196109. eCollection 2019.


Asthma-COPD Overlap Shows Favorable Clinical Outcomes Compared to Pure COPD in a Korean COPD Cohort.

Park HJ, Byun MK, Kim HJ, Ahn CM, Lee JH, Shin KC, Uh ST, Ra SW, Yoo KH, Jung KS.

Allergy Asthma Immunol Res. 2017 Sep;9(5):431-437. doi: 10.4168/aair.2017.9.5.431.


Heterogeneity of asthma and COPD overlap.

Kim MH, Rhee CK, Kim K, Kim SH, Lee JY, Kim YH, Yoo KH, Cho YJ, Jung KS, Lee JH.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 17;13:1251-1260. doi: 10.2147/COPD.S152916. eCollection 2018.


Factors associated with exacerbation in mild- to-moderate COPD patients.

Kim JK, Lee SH, Lee BH, Lee CY, Kim do J, Min KH, Kim SK, Yoo KH, Jung KS, Hwang YI.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 16;11:1327-33. doi: 10.2147/COPD.S105583. eCollection 2016.


Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.

Lee H, Jhun BW, Cho J, Yoo KH, Lee JH, Kim DK, Lee JD, Jung KS, Lee JY, Park HY.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 13;12:3301-3310. doi: 10.2147/COPD.S145910. eCollection 2017.


Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.

Lee JY, Chon GR, Rhee CK, Kim DK, Yoon HK, Lee JH, Yoo KH, Lee SH, Lee SY, Kim TE, Kim TH, Park YB, Hwang YI, Kim YS, Jung KS.

J Korean Med Sci. 2016 Apr;31(4):553-60. doi: 10.3346/jkms.2016.31.4.553. Epub 2016 Mar 10.


Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.

Chubachi S, Sato M, Kameyama N, Tsutsumi A, Sasaki M, Tateno H, Nakamura H, Asano K, Betsuyaku T; Keio COPD Comorbidity Research (K-CCR) Group.

Respir Med. 2016 Aug;117:272-9. doi: 10.1016/j.rmed.2016.07.002. Epub 2016 Jul 7.


Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD.

Braeken DCW, Spruit MA, Houben-Wilke S, Smid DE, Rohde GGU, Wouters EFM, Franssen FME.

Respirology. 2017 Jul;22(5):942-949. doi: 10.1111/resp.12987. Epub 2017 Jan 31.


A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.

Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, Tsuji D, Inoue K, Itoh K.

Clin Exp Allergy. 2017 Nov;47(11):1374-1382. doi: 10.1111/cea.12970. Epub 2017 Aug 1.


The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.

Martin AL, Marvel J, Fahrbach K, Cadarette SM, Wilcox TK, Donohue JF.

Respir Res. 2016 Apr 16;17:40. doi: 10.1186/s12931-016-0356-1. Review.


A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality.

Loh LC, Ong CK, Koo HJ, Lee SM, Lee JS, Oh YM, Seo JB, Lee SD.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 22;13:2543-2550. doi: 10.2147/COPD.S165898. eCollection 2018.


Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.

Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D'Andrea P.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 5;10:57-68. doi: 10.2147/COPD.S72650. eCollection 2015. Erratum in: Int J Chron Obstruct Pulmon Dis. 2015;10:1513.


Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.

Cheng SL, Wang HH, Lin CH.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 31;12:2231-2238. doi: 10.2147/COPD.S140748. eCollection 2017.


Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.

Howcroft M, Walters EH, Wood-Baker R, Walters JA.

Cochrane Database Syst Rev. 2016 Dec 19;12:CD005074. doi: 10.1002/14651858.CD005074.pub4. Review.


Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).

Ni H, Moe S, Soe Z, Myint KT, Viswanathan KN.

Cochrane Database Syst Rev. 2018 Dec 11;12:CD011594. doi: 10.1002/14651858.CD011594.pub2.


Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?

Kim J, Kim WJ, Lee CH, Lee SH, Lee MG, Shin KC, Yoo KH, Lee JH, Lim SY, Na JO, Hwang HG, Hong Y, Lim MN, Yoo CG, Jung KS, Lee SD.

Respir Res. 2017 May 30;18(1):107. doi: 10.1186/s12931-017-0587-9.

Supplemental Content

Support Center